https://www.aigom.it/wp-content/uploads/2024/03/loc8.9marzo-e1714725438367.png558400Alessia Losihttps://www.aigom.it/wp-content/uploads/2022/12/logo-sito.pngAlessia Losi2024-03-14 09:16:202024-05-03 08:37:28VENERDÌ 8 – SABATO 9 MARZO 2024 NEGRAR DI VALPOLICELLA (VR) SCUOLA DI METODOLOGIA DELLA RICERCA CLINICA
https://www.aigom.it/wp-content/uploads/2024/03/jco8.3.png869923Luisahttps://www.aigom.it/wp-content/uploads/2022/12/logo-sito.pngLuisa2024-03-08 08:09:282024-03-08 08:09:28EFFECT OF HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY ON CYTOREDUCTIVE SURGERY IN GASTRIC CANCER WITH SYNCHRONOUS PERITONEAL METASTASES: THE PHASE III GASTRIPEC-I TRIAL
https://www.aigom.it/wp-content/uploads/2024/02/JCO29.png863893Luisahttps://www.aigom.it/wp-content/uploads/2022/12/logo-sito.pngLuisa2024-02-29 13:19:132024-03-01 08:38:53RANDOMIZED PHASE III STUDY COMPARING NEOADJUVANT CHEMOTHERAPY FOLLOWED BY SURGERY VS CHEMORADIATION IN STAGE IB2-IIB2 CERCIVAL CANCER: EORTC-5594
https://www.aigom.it/wp-content/uploads/2024/02/16-17FEBB-PREV.jpg7931052Alessia Losihttps://www.aigom.it/wp-content/uploads/2022/12/logo-sito.pngAlessia Losi2024-02-23 14:46:172024-02-28 08:42:42VENERDÌ 16 – SABATO 17 FEBBRAIO 2024 NEGRAR DI VALPOLICELLA (VR) SCUOLA DI METODOLOGIA DELLA RICERCA CLINICA
https://www.aigom.it/wp-content/uploads/2024/02/ARTICOLO-15feb.jpg821581Alessia Losihttps://www.aigom.it/wp-content/uploads/2022/12/logo-sito.pngAlessia Losi2024-02-15 15:00:492024-02-15 15:00:49ATEZOLIZUMAB CON O SENZA RADIOTERAPIA PER IL CARCINOMA SQUAMOSO AVANZATO DEL PENE (STUDIO PERICLES): TRIAL DI FASE II
https://www.aigom.it/wp-content/uploads/2024/02/ARTICOLO-9febb.jpg821581Alessia Losihttps://www.aigom.it/wp-content/uploads/2022/12/logo-sito.pngAlessia Losi2024-02-09 13:42:322024-02-09 13:43:30STUDIO KATHERINE: T-DM1 adiuvante vs trastuzumab per EBC HER2+ con malattia residua dopo terapia neoadiuvante (chemioterapia e anti-HER2). Analisi finale della IDFS e seconda interim analisi della OS.
https://www.aigom.it/wp-content/uploads/2024/01/CRITICAL-REVIEWS.jpg821581Alessia Losihttps://www.aigom.it/wp-content/uploads/2022/12/logo-sito.pngAlessia Losi2024-01-26 10:33:532024-01-26 10:33:53PRACTICAL GUIDELINES FOR MOLECULAR TESTING OF CHOLANGIOCARCINOMA IN CLINICAL PRACTICE: ITALIAN EXPERTS’ POSITION PAPER.
https://www.aigom.it/wp-content/uploads/2024/01/ARTICOLO-1801.jpg821581Alessia Losihttps://www.aigom.it/wp-content/uploads/2022/12/logo-sito.pngAlessia Losi2024-01-18 14:53:452024-01-18 14:53:45CARDIOVASCULAR DISEASE IN TESTICULAR CANCER SURVIVORS: IDENTIFICATION OF RISK FACTORS AND IMPACT ON QUALITY OF LIFE.
https://www.aigom.it/wp-content/uploads/2023/12/MONARCH-3.jpg821581Alessia Losihttps://www.aigom.it/wp-content/uploads/2022/12/logo-sito.pngAlessia Losi2023-12-21 10:43:542023-12-21 10:44:14MONARCH 3: Risultati dell’analisi finale della sopravvivenza globale presentati al San Antonio Breast Cancer Symposium (SABCS) il 6 dicembre 2023.
